Literature DB >> 11032330

Behaviour and school achievement in patients with early and continuously treated phenylketonuria.

B A Stemerdink1, A F Kalverboer, J J van der Meere, M W van der Molen, J Huisman, L W de Jong, F M Slijper, P H Verkerk, F J van Spronsen.   

Abstract

Thirty patients with early and continuously treated phenylketonuria (PKU) between 8 and 20 years of age were compared with 30 controls, matched individually for age, sex, and educational level of both parents, on behaviour rating scales for parents and teachers as well as a school achievement scale. PKU patients, as a group, demonstrated more problems in task-oriented behaviour and average academic performance than did matched controls. Interestingly, whereas male PKU patients were rated significantly lower on introversion by their teachers, female patients were rated significantly higher on introversion and lower on extraversion than matched controls. This sex difference was also reflected in the relationship between measures of dietary control and the behaviour clusters, suggesting that male and female patients respond differently to elevated Phe levels or the stress associated with PKU. The teacher rating on average academic performance of the PKU patients was associated with recent level of dietary control, which suggests that it might be improved by more strict adherence to the diet. In addition, academic performance correlated negatively with the behaviour cluster negative task orientation. Further studies are recommended to obtain a more complete evaluation of this relationship and to replicate the current findings on larger samples. Over the years a number of studies have examined behaviour and school achievement in patients with early treated phenylketonuria (PKU; McKusick 261600). In general, these studies have found that despite early treatment with a phenylalanine (Phe)-restricted diet, PKU patients demonstrate more behavioural and school problems than do healthy controls. The behaviour problems include both internalizing symptoms (e.g. solitary, unresponsive, anxious, depressed mood: Pietz et al 1997; Smith et al 1988; Weglage et al 1992) and externalizing symptoms (e.g. hyperactive, talkative, impulsive, restless: Hendrikx et al 1994; Kalverboer et al 1994; Realmuto et al 1986; Smith et al 1988), but not antisocial or socially negative symptoms (e.g. lying, teasing, disobedience: Kalverboer et al 1994; Pietz et al 1997; Smith et al 1988). With respect to school achievement, studies have shown that patients with early treated PKU more often repeat classes or need special tutoring (Berry et al 1979; Brunner et al 1983; Koch et al 1987; Rey et al 1996; Verkerk 1995), have to work harder than healthy controls to achieve the same results (Weglage et al 1993), or have specific deficits in arithmetic achievement scores (Azen et al 1991; Berry et al 1979; Fishler et al 1987; Koch et al 1987; Weglage et al 1993). Nevertheless, many questions regarding the behavioural and school problems of patients with early treated PKU remain unanswered. For instance, the relationship between behavioural and school problems on the one hand and levels of dietary control on the other is still relatively unclear. The few studies that examined this relationship, have focused primarily on children in primary school (Azen et al 1991; Koch et al 1987; Smith et al 1988). Furthermore, although several psychological studies have shown that the pattern of behavioural problems varies by sex (see Prior et al 1999a for a discussion), so far very few studies have examined this issue in PKU patients and results are contradictory (Kalverboer et al 1994; Pietz et al 1997; Smith et al 1988; Weglage et al 1992). In addition, so far no study has actually examined whether there is a relationship between the behavioural problems and school difficulties of PKU patients, even though this relationship has been well documented in the psychological literature (Prior et al 1999b; Richards et al 1995). The aim of the present study is therefore to examine these issues in patients with early and continuously treated PKU over a wide age range and in relation to dietary control. More specifically, school achievement as well as social and task-oriented behaviour (at home

Entities:  

Mesh:

Year:  2000        PMID: 11032330     DOI: 10.1023/a:1005669610722

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  18 in total

1.  Psychiatric disorders in adult patients with early-treated phenylketonuria.

Authors:  J Pietz; B Fätkenheuer; P Burgard; M Armbruster; G Esser; H Schmidt
Journal:  Pediatrics       Date:  1997-03       Impact factor: 7.124

2.  The effects of diet discontinuation in children with phenylketonuria.

Authors:  R Koch; C G Azen; N Hurst; E G Friedman; K Fishler
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

3.  Psychiatric diagnosis and behavioral characteristics of phenylketonuric children.

Authors:  G M Realmuto; B D Garfinkel; M Tuchman; M Y Tsai; P N Chang; R O Fisch; S Shapiro
Journal:  J Nerv Ment Dis       Date:  1986-09       Impact factor: 2.254

4.  Early-treated phenylketonuria: neuropsychologic consequences.

Authors:  R L Brunner; M K Jordan; H K Berry
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

5.  School performance and intellectual outcome in adolescents with phenylketonuria.

Authors:  J Weglage; B Fünders; B Wilken; D Schubert; K Ullrich
Journal:  Acta Paediatr       Date:  1993 Jun-Jul       Impact factor: 2.299

6.  [20-year national screening for phenylketonuria in The Netherlands. National Guidance Commission PKU].

Authors:  P H Verkerk
Journal:  Ned Tijdschr Geneeskd       Date:  1995-11-11

7.  Psychological and social findings in adolescents with phenylketonuria.

Authors:  J Weglage; B Fünders; B Wilken; D Schubert; E Schmidt; P Burgard; K Ullrich
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

8.  Social behaviour and task orientation in early-treated PKU.

Authors:  A F Kalverboer; L W van der Schot; M M Hendrikx; J Huisman; F M Slijper; B A Stemerdink
Journal:  Acta Paediatr Suppl       Date:  1994-12

9.  Predictors of mean phenylalanine levels during the first five years of life in patients with phenylketonuria who were treated early. Dutch National PKU Steering Committee.

Authors:  P H Verkerk; F J van Spronsen; M van Houten; G P Smit; R C Sengers
Journal:  Acta Paediatr Suppl       Date:  1994-12

10.  Phenylketonuria and some aspects of emotional development.

Authors:  M M Hendrikx; L W van der Schot; F M Slijper; J Huisman; A F Kalverboer
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

View more
  25 in total

1.  Behavioural factors related to metabolic control in patients with phenylketonuria.

Authors:  M R Crone; F J van Spronsen; K Oudshoorn; J Bekhof; G van Rijn; P H Verkerk
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Nutritional Changes and Micronutrient Supply in Patients with Phenylketonuria Under Therapy with Tetrahydrobiopterin (BH(4)).

Authors:  A G Thiele; J F Weigel; B Ziesch; C Rohde; U Mütze; U Ceglarek; J Thiery; A S Müller; W Kiess; S Beblo
Journal:  JIMD Rep       Date:  2012-10-17

3.  Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Authors:  Emily A Sawin; Sangita G Murali; Denise M Ney
Journal:  Mol Genet Metab       Date:  2014-02-08       Impact factor: 4.797

4.  Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life.

Authors:  B Ziesch; J Weigel; A Thiele; U Mütze; C Rohde; U Ceglarek; J Thiery; W Kiess; S Beblo
Journal:  J Inherit Metab Dis       Date:  2012-03-06       Impact factor: 4.982

5.  Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents.

Authors:  Eva Thimm; Lisa Elena Schmidt; Katrin Heldt; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2013-01-08       Impact factor: 4.982

6.  Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria.

Authors:  Krista S Viau; Heidi J Wengreen; Sharon L Ernst; Nancy L Cantor; Larissa V Furtado; Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

7.  Transition of young adults with phenylketonuria from pediatric to adult care.

Authors:  Ulrike Mütze; Annika Roth; Johannes F W Weigel; Skadi Beblo; Christoph G Baerwald; Peter Bührdel; Wieland Kiess
Journal:  J Inherit Metab Dis       Date:  2011-02-09       Impact factor: 4.982

8.  Contributions of Neuroscience to Our Understanding of Cognitive Development.

Authors:  Adele Diamond; Dima Amso
Journal:  Curr Dir Psychol Sci       Date:  2008-04

9.  Phenylalanine tolerance can already reliably be assessed at the age of 2 years in patients with PKU.

Authors:  F J van Spronsen; M van Rijn; B Dorgelo; M Hoeksma; A M Bosch; M F Mulder; J B C de Klerk; T de Koning; M Estela Rubio-Gozalbo; M de Vries; P H Verkerk
Journal:  J Inherit Metab Dis       Date:  2009-01-10       Impact factor: 4.982

Review 10.  Phenylketonuria: translating research into novel therapies.

Authors:  Gladys Ho; John Christodoulou
Journal:  Transl Pediatr       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.